Concepedia

Markus Alter

MA

Statistics

Publications

19

Citations

842

H-Index

16

Active since

1968

Affiliations

Charité - Universitätsmedizin Berlin(Current)

University of Potsdam

Boehringer Ingelheim (Germany)

Heidelberg University

University Hospital Heidelberg

Markus Alter is an author at Charité - Universitätsmedizin Berlin specializing in medicine, pharmacology, and renal pathophysiology.

Publications per year

1968–2017

19

Publications

19

DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy

Markus Alter, Ina M. Ott, Karoline von Websky et al. · Kidney & Blood Pressure Research · 2012 · 150 citations

, , +17

Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy

Yuliya Sharkovska, Christoph Reichetzeder, Markus Alter et al. · Journal of Hypertension · 2014 · 103 citations

, , +16

The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy

Oleg Tsuprykov, Ryotaro Ando, Christoph Reichetzeder et al. · Kidney International · 2016 · 91 citations · Full text

, , +17

Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy

Lyubov Chaykovska, Karoline von Websky, Jan Rahnenführer et al. · PLoS ONE · 2011 · 81 citations · Full text

, , +11

Early Urinary and Plasma Biomarkers for Experimental Diabetic Nephropathy

Markus Alter, Axel Kretschmer, Karoline von Websky et al. · Clinical Laboratory · 2012 · 71 citations

, , +17

1–5 of 19